ITEM VIEW

Convalescent plasma or hyperimmune immunoglobulin for people with COVID‐19

dc.contributor.authorNnaji, C. A.en_ZA
dc.contributor.authorIwu, C. J.en_ZA
dc.contributor.authorNdwandwe, D. E.en_ZA
dc.contributor.authorJordan, P.en_ZA
dc.contributor.authorWiysonge, Charles S.en_ZA
dc.date.accessioned2020-10-27T12:37:19Z
dc.date.available2020-10-27T12:37:19Z
dc.date.issued2020-07-16
dc.identifier.citationNnaji, C. A. et al. 2020. Convalescent plasma or hyperimmune immunoglobulin for people with COVID‐19. South African Medical Journal, 110(8):759-760, doi:10.7196/SAMJ.2020.v110i8.15032.
dc.identifier.issn2078-5135 (online)
dc.identifier.issn0256-9574 (print)
dc.identifier.otherdoi:10.7196/SAMJ.2020.v110i8.15032
dc.identifier.urihttp://hdl.handle.net/10019.1/108906
dc.descriptionCITATION: Nnaji, C. A. et al. 2020. Convalescent plasma or hyperimmune immunoglobulin for people with COVID‐19. South African Medical Journal, 110(8):759-760, doi:10.7196/SAMJ.2020.v110i8.15032.
dc.descriptionThe original publication is available at http://www.samj.org.za
dc.description.abstractConvalescent plasma is being considered as a potential therapy for COVID‐19. We highlight and contextualise the findings of a recent Cochrane rapid review that evaluated the effectiveness and safety of convalescent plasma or hyperimmune immunoglobulin transfusion in the treatment of people with COVID‐19. The review found low‐certainty evidence of the therapeutic effectiveness and safety of convalescent plasma. As the novel coronavirus continues to spread in South Africa (SA), convalescent plasma may offer a therapeutic ray of hope for mitigating the morbidity and mortality burdens of the disease. Further investigation of the clinical benefits of the therapy in well-designed studies is needed to provide more evidence that will guide COVID-19 treatment decision-making in the SA context.en_ZA
dc.description.urihttp://www.samj.org.za/index.php/samj/article/view/13019
dc.format.extent2 pages
dc.language.isoen_ZAen_ZA
dc.publisherHealth & Medical Publishing Group
dc.subjectCOVID-19 (Disease) -- Treatment -- South Africaen_ZA
dc.subjectCoronavirus infections -- Treatment -- South Africaen_ZA
dc.subjectViral antibodies -- Research -- South Africaen_ZA
dc.titleConvalescent plasma or hyperimmune immunoglobulin for people with COVID‐19en_ZA
dc.typeArticleen_ZA
dc.description.versionPublisher's version
dc.rights.holderAuthors retain copyright


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

ITEM VIEW